"The third and final interim analysis, when 60% of the randomized target has completed 30 days of follow-up, will occur in the coming weeks"
It's coming!
- Forums
- ASX - By Stock
- MSB
- Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial, page-8
-
- There are more pages in this discussion • 385 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.07 |
Change
0.005(0.47%) |
Mkt cap ! $1.233B |
Open | High | Low | Value | Volume |
$1.08 | $1.10 | $1.06 | $3.371M | 3.135M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 45345 | $1.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.07 | 3875 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3840 | 1.160 |
5 | 9416 | 1.110 |
2 | 2202 | 1.105 |
10 | 25616 | 1.085 |
1 | 139528 | 1.065 |
Price($) | Vol. | No. |
---|---|---|
1.020 | 45832 | 2 |
1.025 | 16581 | 2 |
1.030 | 47446 | 12 |
1.035 | 31012 | 3 |
1.040 | 1856 | 1 |
Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |